JAAD Case Reports (Jul 2020)

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

  • Mohammad Munshi, MD,
  • Alexandra Junge,
  • Karolina Gadaldi, MD,
  • Nikhil Yawalkar, MD,
  • Kristine Heidemeyer, MD

Journal volume & issue
Vol. 6, no. 7
pp. 634 – 636

Abstract

Read online

No abstracts available.

Keywords